SI-BONE, the Santa Clara medical-device company known for its iFuse sacroiliac-joint system, has locked in roughly 50,000 square feet of office and R&D space in North San Jose, a move that would more than double the footprint of its current headquarters. The company will occupy a full building in the Orchard Commons complex, gaining larger floorplates, loading access and heavier electrical capacity suited to device testing and product development. For a public company coming off a strong year, the lease marks a major local expansion of its U.S. operations.
According to ADVFN, SI-BONE agreed to lease approximately 50,485 square feet at 88 West Plumeria Drive in North San Jose. The Form 8-K, filed Feb. 20, 2026, lists Orchard Commons as the property and lays out the core terms and options tied to the transaction.
Lease terms and options
The agreement is slated to begin the earlier of Oct. 1 or the date SI-BONE begins business operations in substantially all the space, and runs for 102 months with a five-year extension option. The company also has a one-time right to take an adjacent 28,531 square feet if that space becomes available, and the filing lists an initial monthly base rent of about $128,737 with scheduled increases of roughly 3% per year. The Form 8-K notes SI-BONE is entitled to rent abatement for the first six months and to tenant-improvement and power-upgrade allowances, according to the company disclosure.
The building and neighborhood
Orchard Commons’ listing for 88 West Plumeria Drive describes the space as a single-story, 50,485-square-foot office/R&D building with features that appeal to medtech and engineering tenants, including a dock platform, grade-level loading and substantial electrical capacity. The CBRE listing highlights an expansive window line, roughly 1,200 amps of power and easy access to North First Street light-rail and local services.
What it means for SI-BONE
SI-BONE currently lists its principal offices at 471 El Camino Real in Santa Clara and occupies roughly 21,848 square feet there, per a prior lease amendment filed in 2024. With full-year 2025 revenue of $200.9 million and a return to positive adjusted EBITDA, the company has the financial footing to justify a larger headquarters and expanded R&D and manufacturing capacity, filings and reporting show.
Local real estate context
Listing services show Orchard Commons has been marketed as a plug-and-play R&D and office option for tenants seeking lab-capable infrastructure and higher power, making the property a logical fit for device makers. The deal underscores steady demand in North San Jose for flexible, single-story floorplates that can accommodate engineering, prototyping and light manufacturing functions…